256 related articles for article (PubMed ID: 21882017)
1. Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles.
Ocal P; Sahmay S; Cetin M; Irez T; Guralp O; Cepni I
J Assist Reprod Genet; 2011 Dec; 28(12):1197-203. PubMed ID: 21882017
[TBL] [Abstract][Full Text] [Related]
2. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
[TBL] [Abstract][Full Text] [Related]
3. Interactions between serum FSH, inhibin B and antral follicle count in the decline of serum AMH during the menstrual cycle in late reproductive age.
Robertson DM; Lee CH; Baerwald A
Endocrinol Diabetes Metab; 2021 Apr; 4(2):e00172. PubMed ID: 33855196
[TBL] [Abstract][Full Text] [Related]
4. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
[TBL] [Abstract][Full Text] [Related]
5. Serum anti-müllerian hormone, follicle stimulating hormone and antral follicle count measurement cannot predict pregnancy rates in IVF/ICSI cycles.
Sahmay S; Demirayak G; Guralp O; Ocal P; Senturk LM; Oral E; Irez T
J Assist Reprod Genet; 2012 Jul; 29(7):589-95. PubMed ID: 22492221
[TBL] [Abstract][Full Text] [Related]
6. A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation.
Jayaprakasan K; Campbell B; Hopkisson J; Johnson I; Raine-Fenning N
Fertil Steril; 2010 Feb; 93(3):855-64. PubMed ID: 19046583
[TBL] [Abstract][Full Text] [Related]
7. Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure.
Knauff EA; Eijkemans MJ; Lambalk CB; ten Kate-Booij MJ; Hoek A; Beerendonk CC; Laven JS; Goverde AJ; Broekmans FJ; Themmen AP; de Jong FH; Fauser BC;
J Clin Endocrinol Metab; 2009 Mar; 94(3):786-92. PubMed ID: 19066296
[TBL] [Abstract][Full Text] [Related]
8. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
[TBL] [Abstract][Full Text] [Related]
9. Antral follicle count determines poor ovarian response better than anti-Müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles.
Mutlu MF; Erdem M; Erdem A; Yildiz S; Mutlu I; Arisoy O; Oktem M
J Assist Reprod Genet; 2013 Jun; 30(5):657-65. PubMed ID: 23508679
[TBL] [Abstract][Full Text] [Related]
10. [Value of serum inhibin B measurement in predicting ovarian response in controlled ovarian hyperstimulation for in vitro fertilization cycle].
Chen Y; Yu Q; Zhang YW; He FF; Sun ZY
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):368-71. PubMed ID: 16831355
[TBL] [Abstract][Full Text] [Related]
11. Association of ovarian response with picoAMH in women undergoing controlled ovarian hyperstimulation.
Bruno-Gaston J; Jung J; Kumar T; Zarutskie P; Gibbons W; Devaraj S
Clin Biochem; 2021 Sep; 95():34-40. PubMed ID: 34000288
[TBL] [Abstract][Full Text] [Related]
12. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?
Muttukrishna S; McGarrigle H; Wakim R; Khadum I; Ranieri DM; Serhal P
BJOG; 2005 Oct; 112(10):1384-90. PubMed ID: 16167941
[TBL] [Abstract][Full Text] [Related]
13. Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization.
Lukaszuk K; Kunicki M; Liss J; Lukaszuk M; Jakiel G
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):173-7. PubMed ID: 23485092
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Ovarian Reserve Tests and Age in the Prediction of Poor Ovarian Response to Controlled Ovarian Stimulation-A Real-World Data Analysis of 89,002 Patients.
Wang X; Jin L; Mao YD; Shi JZ; Huang R; Jiang YN; Zhang CL; Liang XY
Front Endocrinol (Lausanne); 2021; 12():702061. PubMed ID: 34526967
[TBL] [Abstract][Full Text] [Related]
15. Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome.
Zhang F; Liu XL; Rong N; Huang XW
J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):70-73. PubMed ID: 28224431
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of antral follicle count and serum anti-Müllerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment?
Lee Y; Kim TH; Park JK; Eum JH; Lee HJ; Kim J; Lyu SW; Kim YS; Lee WS; Yoon TK
Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():151-155. PubMed ID: 29306180
[TBL] [Abstract][Full Text] [Related]
17. [Estimation of ovarian response using multiple predictors of ovarian reserve in women undergoing in vitro fertilization-embryo transfer].
He Y; Xia R; Chen X; Ye D; Tang Y; Li P; Niu J; Chen S
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):216-20. PubMed ID: 23443775
[TBL] [Abstract][Full Text] [Related]
18. Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome.
Eldar-Geva T; Ben-Chetrit A; Spitz IM; Rabinowitz R; Markowitz E; Mimoni T; Gal M; Zylber-Haran E; Margalioth EJ
Hum Reprod; 2005 Nov; 20(11):3178-83. PubMed ID: 16113044
[TBL] [Abstract][Full Text] [Related]
19. Hormonal and functional biomarkers in ovarian response.
Vural B; Cakiroglu Y; Vural F; Filiz S
Arch Gynecol Obstet; 2014 Jun; 289(6):1355-61. PubMed ID: 24366586
[TBL] [Abstract][Full Text] [Related]
20. Anti-müllerian hormone compared with other ovarian markers after childhood cancer treatment.
Nyström A; Mörse H; Nordlöf H; Wiebe K; Artman M; Øra I; Giwercman A; Henic E; Elfving M
Acta Oncol; 2019 Feb; 58(2):218-224. PubMed ID: 30558460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]